In the notice with the above title, published in the New Zealand Gazette, 27 March 2026, Notice No. 2026-go1709 replace:

“Active Ingredients and Concentrations:

Each dose (0.5 mL) of reconstituted vaccine contains:

Live attenuated feline herpesvirus type 1, strain G2620A: 105.8 – 107.1 PFU*

Live attenuated feline calicivirus, strain F9: 104.6 – 107.0 PFU*

*Plaque forming units.”

With

“Active Ingredients and Concentrations:

Each dose (0.5 mL) of reconstituted vaccine contains:

Live attenuated feline herpesvirus type 1, strain G2620A: 10^5.8 – 10^7.1 PFU*

Live attenuated feline calicivirus, strain F9: 10^4.6 – 10^7.0 PFU*

*Plaque forming units.”

Dated at Wellington this 2nd day of April 2026.

SHALEEN NARAYAN, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).